240 related articles for article (PubMed ID: 10922410)
1. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
Bärlund M; Forozan F; Kononen J; Bubendorf L; Chen Y; Bittner ML; Torhorst J; Haas P; Bucher C; Sauter G; Kallioniemi OP; Kallioniemi A
J Natl Cancer Inst; 2000 Aug; 92(15):1252-9. PubMed ID: 10922410
[TBL] [Abstract][Full Text] [Related]
2. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P ; Kallioniemi A
Cancer Res; 2000 Oct; 60(19):5340-4. PubMed ID: 11034067
[TBL] [Abstract][Full Text] [Related]
3. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
Bärlund M; Tirkkonen M; Forozan F; Tanner MM; Kallioniemi O; Kallioniemi A
Genes Chromosomes Cancer; 1997 Dec; 20(4):372-6. PubMed ID: 9408753
[TBL] [Abstract][Full Text] [Related]
4. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
5. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer.
Monni O; Barlund M; Mousses S; Kononen J; Sauter G; Heiskanen M; Paavola P; Avela K; Chen Y; Bittner ML; Kallioniemi A
Proc Natl Acad Sci U S A; 2001 May; 98(10):5711-6. PubMed ID: 11331760
[TBL] [Abstract][Full Text] [Related]
7. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Couch FJ; Wang XY; Wu GJ; Qian J; Jenkins RB; James CD
Cancer Res; 1999 Apr; 59(7):1408-11. PubMed ID: 10197603
[TBL] [Abstract][Full Text] [Related]
8. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
[TBL] [Abstract][Full Text] [Related]
9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Forozan F; Mahlamäki EH; Monni O; Chen Y; Veldman R; Jiang Y; Gooden GC; Ethier SP; Kallioniemi A; Kallioniemi OP
Cancer Res; 2000 Aug; 60(16):4519-25. PubMed ID: 10969801
[TBL] [Abstract][Full Text] [Related]
11. CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors.
Heiskanen M; Kononen J; Bärlund M; Torhorst J; Sauter G; Kallioniemi A; Kallioniemi O
Anal Cell Pathol; 2001; 22(4):229-34. PubMed ID: 11564899
[TBL] [Abstract][Full Text] [Related]
12. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.
Wu GJ; Sinclair CS; Paape J; Ingle JN; Roche PC; James CD; Couch FJ
Cancer Res; 2000 Oct; 60(19):5371-5. PubMed ID: 11034073
[TBL] [Abstract][Full Text] [Related]
13. Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.
Latham C; Zhang A; Nalbanti A; Månér S; Zickert P; Blegen H; Zetterberg A
Cancer Genet Cytogenet; 2001 May; 127(1):16-23. PubMed ID: 11408059
[TBL] [Abstract][Full Text] [Related]
14. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
Willis S; Hutchins AM; Hammet F; Ciciulla J; Soo WK; White D; van der Spek P; Henderson MA; Gish K; Venter DJ; Armes JE
Genes Chromosomes Cancer; 2003 Apr; 36(4):382-92. PubMed ID: 12619162
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.
Erson AE; Niell BL; DeMers SK; Rouillard JM; Hanash SM; Petty EM
Neoplasia; 2001; 3(6):521-6. PubMed ID: 11774034
[TBL] [Abstract][Full Text] [Related]
16. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones.
Clark J; Edwards S; John M; Flohr P; Gordon T; Maillard K; Giddings I; Brown C; Bagherzadeh A; Campbell C; Shipley J; Wooster R; Cooper CS
Genes Chromosomes Cancer; 2002 May; 34(1):104-14. PubMed ID: 11921288
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract][Full Text] [Related]
18. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
[TBL] [Abstract][Full Text] [Related]
19. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
20. A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization.
Watanabe T; Imoto I; Kosugi Y; Ishiwata I; Inoue S; Takayama M; Sato A; Inazawa J
Gynecol Oncol; 2001 May; 81(2):172-7. PubMed ID: 11330945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
